Publications by authors named "Peter Morgan-Warren"

Claim this Profile
I
Intravitreal Aflibercept 8 mg in Neovascular Age-Related Macular Degeneration: Ninety-Six-Week Results from the Randomized Phase 3 PULSAR Trial.
Jean-François Korobelnik, Paolo Lanzetta, Sergio Leal, Frank G Holz, W Lloyd Clark, Peter Morgan-Warren

Ophthalmology· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravitreal Aflibercept 8 mg for Diabetic Macular Edema: 96-Week Results from the Randomized Phase 2/3 PHOTON Trial.
Diana V Do, Charles C Wykoff, Sobha Sivaprasad, David M Brown, David S Boyer, Peter J Morgan-Warren

Ophthalmology· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2-year results from an observational study of proactive treatment regimens with intravitreal aflibercept 2 mg in patients with nAMD in clinical practice: XTEND study UK cohort.
Clare Bailey, Manju Chandran, Richard Gale, Nirodhini Narendran, James Talks, Peter Morgan-Warren

Eye (Lond)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infographic: Efficacy and safety of high-dose intravitreal aflibercept 8 mg in patients with diabetic macular oedema: Week 48 results from the phase 2/3 PHOTON trial.
Sobha Sivaprasad, Kimberly Reed, Peter Morgan-Warren, Sergio Leal, Alyson Berliner

Eye (Lond)· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained disease control with aflibercept 8 mg: a new benchmark in the management of retinal neovascular diseases.
Jean-François Korobelnik, Paolo Lanzetta, Charles C Wykoff, Tien Y Wong, Xin Zhang, Peter Morgan-Warren

Eye (Lond)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expert Panel Consensus for Optimizing Outcomes in Neovascular Age-Related Macular Degeneration in the Context of Suboptimal Response to a Biosimilar: The Role of Aflibercept.
Nirodhini Narendran, Clare Bailey, Louise Downey, Richard Gale, Ajay Kotagiri, Peter Morgan-Warren

Clin Ophthalmol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world service costs for neovascular-AMD clinics in the United Kingdom: structured literature review and scenario analysis.
Sobha Sivaprasad, Clare Bailey, Louise Downey, Rose Gilbert, Richard Gale, Peter Morgan-Warren

Curr Med Res Opin· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of standard-of-care intravitreal aflibercept treatment practices in patients with diabetic macular oedema in the UK: DRAKO study outcomes.
Sobha Sivaprasad, Faruque Ghanchi, Simon P Kelly, Ajay Kotagiri, James Talks, Peter Morgan-Warren

Eye (Lond)· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practical implementation of a q4-q16 aflibercept treat-and-extend pathway for the treatment of neovascular age-related macular degeneration: Updated guidance from a UK expert panel.
Clare Bailey, Peter Cackett, Ajay Kotagiri, Sajjad Mahmood, Evangelos Minos, Peter Morgan-Warren

Eye (Lond)· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reported Rates of Intraocular Inflammation with Intravitreal Aflibercept Administered via Pre-Filled Syringe or from Vials in Clinical Practice Between 2012 and 2022.
Ursula Schmidt-Ott, Scott Fitzpatrick, Zoran Hasanbasic, Sergio Leal, Peter Morgan-Warren

Clin Ophthalmol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in licence approvals for ophthalmic medicines in the United Kingdom.
Peter J Morgan-Warren, Jiten B Morarji

Eye (Lond)· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ophthalmic medicine regulatory approvals through the European Centralised Procedure, 1999-2017: Clinical efficacy considerations.
Peter J Morgan-Warren

Eur J Ophthalmol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of siRNA-Mediated Knockdown of GSK3β on Retinal Ganglion Cell Survival and Neurite/Axon Growth.
Zubair Ahmed, Peter J Morgan-Warren, Martin Berry, Robert A H Scott, Ann Logan

Cells· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thermosensitive hydrogel as an in situ gelling antimicrobial ocular dressing.
S Mohammed, Gurpreet Chouhan, Olachi Anuforom, Megan Cooke, Anna Walsh, Peter Morgan-Warren

Mater Sci Eng C Mater Biol Appl· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Topical Delivery of Anti-VEGF Drugs to the Ocular Posterior Segment Using Cell-Penetrating Peptides.
Felicity de Cogan, Lisa J Hill, Aisling Lynch, Peter J Morgan-Warren, Judith Lechner

Invest Ophthalmol Vis Sci· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Prospects for mTOR-mediated functional repair after central nervous system trauma" [Neurobiol. Dis. 85 (2016) 99-110].
Martin Berry, Zubair Ahmed, Peter Morgan-Warren, Daniel Fulton, Ann Logan

Neurobiol Dis· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
siRNA-Mediated Knockdown of the mTOR Inhibitor RTP801 Promotes Retinal Ganglion Cell Survival and Axon Elongation by Direct and Indirect Mechanisms.
Peter J Morgan-Warren, Jenna O'Neill, Felicity de Cogan, Igor Spivak, Hagit Ashush

Invest Ophthalmol Vis Sci· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospects for mTOR-mediated functional repair after central nervous system trauma.
Martin Berry, Zubair Ahmed, Peter Morgan-Warren, Daniel Fulton, Ann Logan

Neurobiol Dis· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decorin Reduces Intraocular Pressure and Retinal Ganglion Cell Loss in Rodents Through Fibrolysis of the Scarred Trabecular Meshwork.
Lisa J Hill, Ben Mead, Richard J Blanch, Zubair Ahmed, Felicity De Cogan, Peter J Morgan-Warren

Invest Ophthalmol Vis Sci· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opacification of hydrophilic intraocular lenses after Descemet stripping automated endothelial keratoplasty.
Peter J Morgan-Warren, Walter Andreatta, Amit K Patel

Clin Ophthalmol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral ulcerative keratitis as the presenting feature of systemic rheumatoid vasculitis without joint involvement.
Peter J Morgan-Warren, Simon Dulku, Jaya Ravindran, George Smith

Int Ophthalmol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Visual function and quality of life in patients who had undergone eye removal surgery: a patient survey.
Peter J Morgan-Warren, Purnima Mehta, Harpreet S Ahluwalia

Orbit· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploiting mTOR signaling: a novel translatable treatment strategy for traumatic optic neuropathy?
Peter J Morgan-Warren, Martin Berry, Zubair Ahmed, Robert A H Scott, Ann Logan

Invest Ophthalmol Vis Sci· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intraocular lens-edge design and material factors contributing to posterior-capsulotomy rates: comparing Hoya FY60aD, PY60aD, and AcrySof SN60WF.
Peter J Morgan-Warren, Jm Alaric Smith

Clin Ophthalmol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lacrimal duct cyst (dacryops) following ocular chemical injury.
Peter J Morgan-Warren, Simon N Madge

Orbit· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis